Ratio Therapeutics Raises $50M in Series B Financing
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
Stay updated with breaking news from Jack Hoppin. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
Boston-based radiopharmaceutical company Ratio Therapeutics has opened a new 19,000 square foot headquarters and R&D facility.
BALTIMORE — EMIT IMAGING, Inc. (“EMIT” or the “Company”) is pleased to announce the appointment of Dr. Matthew Silva as the company’s new Chief Executive…
Collaboration to develop a Granzyme B-targeted agent for PET imaging applications in inflammation and cancer indications
/PRNewswire/ -- Ratio Therapeutics Inc. (Ratio), a pharmaceutical company specializing in the development of targeted radiotherapeutics for the treatment of...